299 related articles for article (PubMed ID: 31855262)
1. The Australian Calciphylaxis Registry: reporting clinical features and outcomes of patients with calciphylaxis.
Ruderman I; Toussaint ND; Hawley CM; Krishnasamy R; Pedagogos E; Lioufas N; Elder GJ
Nephrol Dial Transplant; 2021 Mar; 36(4):649-656. PubMed ID: 31855262
[TBL] [Abstract][Full Text] [Related]
2. Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry.
Brandenburg VM; Kramann R; Rothe H; Kaesler N; Korbiel J; Specht P; Schmitz S; Krüger T; Floege J; Ketteler M
Nephrol Dial Transplant; 2017 Jan; 32(1):126-132. PubMed ID: 26908770
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and risk factors associated with mortality in calcific uremic arteriolopathy.
Santos PW; He J; Tuffaha A; Wetmore JB
Int Urol Nephrol; 2017 Dec; 49(12):2247-2256. PubMed ID: 29058165
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and outcomes of calciphylaxis in Chinese patients with chronic kidney disease.
Jiao Y; Sun L; Xie X; Liu H; Zhao Y; Ni H; Zhang X
Nephrology (Carlton); 2023 Jun; 28(6):305-314. PubMed ID: 36883928
[TBL] [Abstract][Full Text] [Related]
5. Calciphylaxis epidemiology, risk factors, treatment and survival among French chronic kidney disease patients: a case-control study.
Gaisne R; Péré M; Menoyo V; Hourmant M; Larmet-Burgeot D
BMC Nephrol; 2020 Feb; 21(1):63. PubMed ID: 32101140
[TBL] [Abstract][Full Text] [Related]
6. Calciphylaxis.
Nigwekar SU
Curr Opin Nephrol Hypertens; 2017 Jul; 26(4):276-281. PubMed ID: 28375870
[TBL] [Abstract][Full Text] [Related]
7. Management of Cutaneous Calciphylaxis.
Kodumudi V; Jeha GM; Mydlo N; Kaye AD
Adv Ther; 2020 Dec; 37(12):4797-4807. PubMed ID: 32997277
[TBL] [Abstract][Full Text] [Related]
8. A Fatal Case of Non-Uremic Calciphylaxis: A Case Report and Literature Review.
Abdalla AO; Al-Khafaji J; Taha M; Malik S
Am J Case Rep; 2018 Jul; 19():804-807. PubMed ID: 29983410
[TBL] [Abstract][Full Text] [Related]
9. A case-control study of calciphylaxis in Japanese end-stage renal disease patients.
Hayashi M; Takamatsu I; Kanno Y; Yoshida T; Abe T; Sato Y;
Nephrol Dial Transplant; 2012 Apr; 27(4):1580-4. PubMed ID: 22121234
[TBL] [Abstract][Full Text] [Related]
10. [Calciphylaxis: an enigma to the nephrologist].
Barbera V; Di Lullo L; Otranto G; Barbera G; Santoboni A
G Ital Nefrol; 2012; 29(6):674-82. PubMed ID: 23229665
[TBL] [Abstract][Full Text] [Related]
11. Calcific uremic arteriolopathy (calciphylaxis) calls into question the validity of guidelines of diagnosis and treatment.
Chiriac A; Grosu OM; Terinte C; Perţea M
J Dermatolog Treat; 2020 Aug; 31(5):545-548. PubMed ID: 31075991
[No Abstract] [Full Text] [Related]
12. Calciphylaxis: calcific uraemic arteriolopathy--a case study.
Byrne H; Lloyd S
J Ren Care; 2007; 33(2):74-7. PubMed ID: 17702510
[TBL] [Abstract][Full Text] [Related]
13. Calciphylaxis - A case study in a patient with Maori heritage.
Kingi L; Grech R; Lam M; Dissanayake A; Otter S
J Tissue Viability; 2016 Nov; 25(4):216-219. PubMed ID: 27443245
[TBL] [Abstract][Full Text] [Related]
14. Calciphylaxis in end-stage kidney disease: outcome data from the United Kingdom Calciphylaxis Study.
Chinnadurai R; Huckle A; Hegarty J; Kalra PA; Sinha S
J Nephrol; 2021 Oct; 34(5):1537-1545. PubMed ID: 33548054
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and treatment modalities in uremic and non uremic calciphylaxis - a dermatological single-center experience.
Yousuf S; Busch D; Renner R; Schliep S; Erfurt-Berge C
Ren Fail; 2024 Dec; 46(1):2297566. PubMed ID: 38178572
[TBL] [Abstract][Full Text] [Related]
16. [Calcific uremic arteriolopathy (calciphylaxis)].
Gauthey D; Morisod J; Coutaz M
Rev Med Suisse; 2008 May; 4(156):1167-71. PubMed ID: 18630172
[TBL] [Abstract][Full Text] [Related]
17. Calcific uremic arteriolopathy: a call for action.
Brandenburg VM; Cozzolino M; Mazzaferro S
Semin Nephrol; 2014 Nov; 34(6):641-7. PubMed ID: 25498382
[TBL] [Abstract][Full Text] [Related]
18. Calciphylaxis in patients with chronic kidney disease: A disease which is still bewildering and potentially fatal.
Cucchiari D; Torregrosa JV
Nefrologia (Engl Ed); 2018; 38(6):579-586. PubMed ID: 30415999
[TBL] [Abstract][Full Text] [Related]
19. Use of sodium thiosulphate in a multi-interventional setting for the treatment of calciphylaxis in dialysis patients.
Zitt E; König M; Vychytil A; Auinger M; Wallner M; Lingenhel G; Schilcher G; Rudnicki M; Salmhofer H; Lhotta K
Nephrol Dial Transplant; 2013 May; 28(5):1232-40. PubMed ID: 23291368
[TBL] [Abstract][Full Text] [Related]
20. Calciphylaxis: Controversies in Pathogenesis, Diagnosis and Treatment.
Jeong HS; Dominguez AR
Am J Med Sci; 2016 Feb; 351(2):217-27. PubMed ID: 26897281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
